ProShares Ultra Nasdaq Biotechnology (BIB)

NASDAQ: BIB · Real-Time Price · USD
80.63
-1.46 (-1.78%)
Apr 28, 2026, 2:22 PM EDT - Market open
-1.78%
Assets $85.89M
Expense Ratio 0.95%
PE Ratio n/a
Shares Out 940,000
Dividend (ttm) $0.49
Dividend Yield 0.60%
Ex-Dividend Date Mar 25, 2026
Payout Ratio n/a
1-Year Return +83.46%
Volume 2,417
Open 81.84
Previous Close 82.09
Day's Range 80.57 - 81.84
52-Week Low 39.47
52-Week High 90.91
Beta 1.36
Holdings 264
Inception Date Apr 8, 2010

About BIB

Fund Home Page

The ProShares Ultra Nasdaq Biotechnology (BIB) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index. The fund provides 2x daily exposure to a modified market-cap-weighted index of biotechnology and pharmaceutical companies listed on NASDAQ. BIB was launched on Apr 8, 2010 and is issued by ProShares.

Asset Class Equity
Category Trading--Leveraged Equity
Stock Exchange NASDAQ
Ticker Symbol BIB
ETF Provider ProShares
Index Tracked NASDAQ / Biotechnology

Top 10 Holdings

152.37% of assets
Name Symbol Weight
NASDAQ BIO INDEX SWAP BNP PARIBAS n/a 36.47%
NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA n/a 28.40%
NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA n/a 27.04%
NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL n/a 20.25%
NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE n/a 16.89%
NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG n/a 4.86%
Amgen Inc. AMGN 4.84%
Gilead Sciences, Inc. GILD 4.77%
Vertex Pharmaceuticals Incorporated VRTX 4.72%
Regeneron Pharmaceuticals, Inc. REGN 4.13%
View More Holdings

Dividends

Ex-Dividend Amount Pay Date
Mar 25, 2026 $0.00714 Mar 31, 2026
Dec 24, 2025 $0.13464 Dec 31, 2025
Sep 24, 2025 $0.18054 Sep 30, 2025
Jun 25, 2025 $0.17058 Jul 1, 2025
Mar 26, 2025 $0.13094 Apr 1, 2025
Dec 23, 2024 $0.39644 Dec 31, 2024
Full Dividend History

News

There is no news available yet.